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ABSTRACT
Objectives: To describe the ultrasound features of benign Brenner tumor in the background of complex clinical and 
histopathological pictures.
Material and methods: We retrospectively identified patients with histologically confirmed benign Brenner tumor of 
the ovary who were treated in our institution in 2003–2016, and for whom complete imaging, clinical, perioperative and 
histopathological data were available in the database. Ultrasound findings were drawn from images and reports using 
terms and definitions of the International Ovarian Tumor Analysis group and pattern recognition description was applied.
Results: Twenty-three patients were identified, most postmenopausal and asymptomatic. On ultrasound, 19/23 tumors 
were found unilaterally, 4/23 bilaterally, and 82% of tumors were detected in the left ovary. Most Brenner tumors (16/23) 
contained solid components and revealed no or minimal blood flow by subjective color score upon Doppler examination 
(19/23, 83%). Calcifications with shadowing were observed in 57% of all Brenner tumors and in 81% of tumors containing 
solid components. The complex appearance of the tumor misled the sonographers to describe the mass as malignant in 
9 cases (39%), and frozen section was performed perioperatively. Surgery was performed via laparoscopy in 11 (48%) and 
via laparotomy in 12 (52%) cases.
Conclusions: The complexity of the ultrasound picture, consisting of features like calcifications with acoustic shadowing, 
a poorly vascularized solid mass, and a left-sided localization could be signs of a benign Brenner tumor and could preop-
eratively help to differentiate between benign and malignant tumor.
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INTRODUCTION
A Brenner tumor is an epithelial surface tumor of the 
ovary that was first described by Fritz Brenner in 1907 [1]. It is 
a mostly benign transitional cell tumor and represents about 
3% of ovarian epithelial tumors [2]. Microscopically, the tumor 
consists of sharply demarcated uniform islands of epithelial 
cells in a dense fibromatous stroma. The epithelial cells have 
a characteristic coffee bean nucleus with longitudinal grooves 
and pale cytoplasm [3, 4] (Fig. 1). Tumor can contain extensive 
calcifications. Careful histological examination should be 
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performed in order to exclude even small foci of malignancy 
which may arise from the benign Brenner tumor [5, 6]. Most 
patients are asymptomatic and the tumor is discovered in-
cidentally as a part of routine physical examination and/or 
ultrasound scan performed by a radiologist or gynecologist in 
women of any age but predominantly between 50–70 years 
old [7]. Benign tumors are commonly 5–6 cm in diameter, 
occasionally exceeding 10 cm [8]. Borderline and malignant 
Brenner tumors may measure up to 30 cm [9]. Most women 
are asymptomatic but they can manifest abdominal pain, 
vaginal bleeding due to estrogenic activity, urinary retention, 
ascites or pseudo Meigs’ syndrome [10].
Appropriate preoperative ultrasound examination is 
crucial for distinguishing between benign and malignant ad-
nexal tumors and for further management of ovarian masses 
However, despite well-established International Ovarian Tu-
mor Analysis (IOTA) imaging criteria for ovarian cancer rec-
ognition, ultrasound findings in Brenner tumors overlap 
with those typical of ovarian cancer which contributes to 
serious difficulties in image interpretation [11, 12]. Cur-
rently, there are no recent studies published on this topic 
in the literature. Therefore, we reviewed sonographic and 
clinical data, including the surgical management, on histo-
logically confirmed cases of benign Brenner tumors in our 
institution. In this study, we aim to indicate the ultrasound 
features (morphological and vascular ultrasound patterns) 
of a Brenner tumor and to encourage sonographers dealing 
with ovarian mass findings to improve their knowledge and 
awareness of this rare tumor. The correct preoperative diag-
nosis of a Brenner tumor as a benign pelvic mass enables 
the choice of a less radical surgical procedure and minimizes 
fear in patients who may anticipate ovarian cancer diagnosis.
MATERIAL AND METHODS
Study design and patient population
We conducted a retrospective study of ovarian tumors 
— Brenner tumors that were diagnosed and treated in our 
institution between January 2003 and December 2016. The 
indications for referral for transvaginal and transabdominal 
sonography were inconclusive examination with suspicion 
of gynecological cancer due to a palpable adnexal mass, 
abnormal sonographic findings assessed by a general gy-
necologist or general practitioner with or without elevated 
CA 125 tumor marker, and non-specific abdominal symp-
toms (abdominal/pelvic pain). Most clinical information was 
retrieved retrospectively from the patient records, such as 
age at diagnosis, pre- or postmenopausal status, level of CA 
125 in blood, risk of malignancy index (RMI), symptoms, pres-
ence of ascites according to the IOTA consensus described by 
Timmerman et al. [12], and detailed histological evaluation 
results. Only patients with histologically proven benign Bren-
ner tumors were included in the final analysis. All patients 
underwent surgery and the tumor was removed. Type of 
surgery (laparoscopy or laparotomy) and the extension rang-
ing from unilateral salpingo-oophorectomy to more extensive 
as total hysterectomy, bilateral salpingo-oophorectomy were 
reviewed. Frozen section requests were carefully recorded 
and analyzed. All clinical and ultrasound data were put into 
a dedicated Excel file and then analyzed (Microsoft Office 
Excel 2010). This study was approved by the local ethics com-
mittee and all patients gave their informed consent.
Ultrasound examination
Each patient underwent a pre-operative ultrasound ex-
amination according to the methodology and protocol of 
our institution that consisted of both transabdominal and 
transvaginal examinations performed within 21 days prior 
surgery by a gynecologist experienced in the field of ultra-
sound diagnostics in gynecologic oncology. These were expert 
sonographers with gynecology and oncology experience who 
were certified by the Czech Gynecologic Ultrasound Society 
as high-level experts in oncogynecologic sonography. Sonog-
raphers VW, BCH, and MZ are holders of IOTA certificate. The 
ultrasound examinations were performed in B-mode and color 
and power Doppler mode with both a transvaginal (5–8 MHz) 
and a transabdominal probe (3.5–5 MHz) on a variety of equip-
ment. Each ultrasound examination was immediately de-
scribed in the written report and images were stored; both 
were used in the study analysis. Descriptions and examination 
reports were performed according to the standards in our 
center, that include the terms and definitions published by 
the IOTA group [12]. The reports also included the final assess-
ment of the sonographer whether the mass was suspicious 
for malignancy or not. Results of Doppler examinations were 
reported in terms of a subjective color score [12].
Data analysis and methodology
All clinical and ultrasound parameters were summarized 
using absolute and relative frequencies or median and range 
Figure 1. Brenner tumor: Microscopically, the tumor consists of 
sharply demarcated uniform islands of epithelial cells in a dense 
fibromatous stroma. The epithelial cells have a characteristic coffee 
bean nucleus with longitudinal grooves and pale cytoplasm
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in case of continuous data. All tables were stratified accord-
ing to the clinical, surgical, and ultrasound characteristics of 
the patients. No statistical comparisons were done because 
of the study’s descriptive character.
RESULTS
We retrospectively included 23 patients into the study 
who had histologically proven benign Brenner tumor of 
the ovary in the 14-year time frame. There were no cases of 
malignant Brenner tumors in the analysed period of time. 
The patients’ median age was 58 (range 38–71); only 3 (13%) 
were fertile; no personal or family history of ovarian can-
cer was reported. Eighteen (78%) patients were asympto-
matic while five (22%) presented with abdominal/pelvic 
pain. Results of serum CA 125 measurements were avail-
able for all 23 women; the median level was 19 IU/L (range 
9–240 IU/L); only 2 patients manifested raised CA 125 level. 
In 9 cases, the RMI result was over 200 and those patients 
were considered at significant risk of ovarian malignancy. 
The clinical characteristics together with surgical manage-
ment of all studied patients are described in detail in Ta-
ble 1. The sonographic characteristics (B-mode and Doppler 
findings), including the sonographer’s suggestion if the 
tumor was benign/uncertain or malignant are described 
and summarized in Table 2.
The majority of the tumors (19/23; 82%) were found 
unilaterally; in 4 cases a Brenner tumor was diagnosed 
simultaneously in both ovaries. Looking closer at lateraliza-
tion of the masses, 15 tumors were detected in the left ovary 
only and another 4 were in the left as a part of their bilateral 
presence (overall, the left ovary was affected by tumor in 
82%). The median diameter of the tumor was 62 mm (range 
15–270 mm) and the diameter of the largest solid compo-
nent was 40 mm (range 0–85 mm). The majority, or 16/23 tu-
mors (70%), contained solid components (Fig. 2, Fig. 3) while 
pure cystic content was present in 7 masses (30%) only. The 
cystic fluid was anechogenic in 14 tumors (61%) (Fig. 4) while 
1 (4%) had low-level echogenicity. Ascites with simultane-
ously elevated CA 125 level in blood (240 IU/L) were present 
in 1 patient and no pleural effusion was diagnosed. The color 
score varied between none and moderate at Doppler exami-
nation; no abundantly vascularized tumor was noted. Most 
tumors were minimally perfused (11/23, 48%); no blood 
Table 1. Clinical characteristics and surgical management of 
patients with Brenner tumor
Benign Brenner 
tumor (n = 23)
Age at surgery [years] 58 (38–71)
Serum CA 125 level [IU/L] 19 (9–240)
RMI 81 (36–2430)
Menstruation
Premenopausal 3 (13%)
Postmenopausal 20 (87%)
Symptomatology
Asymptomatic 18 (78%)
Pelvic pain 5 (22%)
Surgery
Frozen section 9 (39%)
Cystectomy Laparoscopy 0 (0%)
Salpingo-oophorectomy Laparoscopy 6 (26%)
Salpingo-oophorectomy Laparotomy 1 (4%)
Total laparoscopic hysterectomy + BSO 5 (22%)
Total abdominal hysterectomy + BSO 11 (48%)
Values are median (range) or n (%); RMI — risk malignancy index;  
BSO — bilateral salpingo-oophorectomy
Table 2. Ultrasound characteristics of Brenner tumor 
Brenner tumor (n = 23)
Largest diameter [mm] 62 (15–270)
Largest solid component [mm] 40 (0–85)
Laterality
Unilateral 19 (82 %)
Bilateral 4 (18%)
Left 19 (82%)
Right 8 (35%)
Type of tumor
Unilocular 4 (17%)
Unilocular-solid 0 (0%)
Multilocular 3 (13%)
Multilocular-solid 8 (35%)
Solid 8 (35%)
Calcifications and acoustic shadowing 13 (57%)
Ascites 1 (4%)
Echogenicity of cyst fluid
Anechogenic 14 (61%)
Ground glass 0 (0%)
Low level 1 (4%)
Doppler results: Color score
None 8 (35%)
Minimal 11 (48%)
Moderate 4 (17%)
Abundant 0 (0%)
Ultrasound diagnosis
Benign 13 (57%)
Uncertain 1 (4%)
Malignant 9 (39%)
Values are median (range) or n (%)
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flow was detected in 8/23 (35%). Shadowing of the acoustic 
signal behind the cyst was observed in 13 tumors which 
represents 57% of all Brenner tumors (Fig. 3, Fig. 5). Applying 
pattern recognition description (Tab. 3), a Brenner tumor 
could be described as follows: 7 masses were unilocular or 
multilocular with no specific characteristics. All these masses 
were correctly classified as benign. Eight tumors were de-
scribed as multilocular solid with calcifications and shadow-
ing behind the mass while solid structures were minimally 
to moderately vascularized at Doppler. Eight masses were 
purely solid with calcifications causing acoustic shadowing 
behind the tumor; the solid part was minimally or moder-
ately vascularized at Doppler. The complex appearance of 
the Brenner tumor misled the sonographers in 9 cases (39%) 
to describe the mass as malignant and frozen section was 
performed perioperatively (Fig. 5, Fig. 6). The features of 
the misclassified benign Brenner tumors were different to 
the others suggested as benign. They were generally larger 
than the median (62 mm) of all Brenner tumors, reaching 
a diameter of 130 mm (range 70–270 mm) and the solid 
component was 70 mm (range 40–85 mm) in comparison 
to the 40 mm median of all Brenner tumors in the study. 
Figure 2. Transabdominal ultrasound image of 10 cm purely solid 
benign Brenner tumor 
Figure 5. Transvaginal ultrasound image of a solid benign Brenner 
tumor containing an anechoic cystic component, calcifications 
(arrows) and acoustic shadowing behind the tumor
Figure 4. Transvaginal ultrasound image of a multilocular–solid Brenner 
tumor. There is a septum in the anechoic cystic component. The internal 
cyst walls are regular with some calcifications foci in the wall
Figure 3. Transvaginal ultrasound image of a purely solid benign 
Brenner tumor with multiple scattered calcifications and acoustic 
shadowing behind the tumor
Table 3. Classification of Brenner tumors according to characteristics on pattern recognition
Brenner tumor 
(n = 23)
N of tumors misdiagnosed as 
malignant in each category
Unilocular or multilocular tumor with no specific characteristics † 7 0
Multilocular solid tumor with calcifications causing shadowing behind the tumor,  
solid structure minimal to moderate vascularized at Doppler 8 6
Solid tumor with calcifications causing shadowing behind the tumor, solid structure 
minimal to moderate vascularized at Doppler 8 3
† solid structure, shadowing, calcifications; N — number
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All bilateral Brenner tumors were preoperatively classified as 
malignant and all 9 misclassified tumors contained a solid 
portion, of these, 3 were purely solid with minimal or moder-
ate vascularization of the solid structures.
All 23 patients in our series underwent surgery and 
the ovarian mass was removed. Among these, no patient 
underwent cystectomy only, 7 patients were treated with 
salpingo-oophorectomy and 16 with total hysterectomy and 
bilateral salpingo-oophorectomy. Surgery was performed 
via laparoscopy in 11 (48%) cases, via laparotomy in 12 (52%) 
cases. Nine patients underwent surgical staging for ovar-
ian cancer, consisting of peritoneal washing, a macroscopic 
assessment of intra-abdominal organs and perioperative 
frozen section. These cases were described as suspicious 
adnexal masses according to the preoperative ultrasound 
examination.
DISCUSSION
We present a series of 23 patients with benign Brenner 
tumors of the ovary diagnosed and treated in our institu-
tion. Clinical characteristics of the cohort are in concordance 
with those previous published [8, 10, 13]. Typically, Brenner 
tumors occur in postmenopausal women. Most patients 
were asymptomatic and the pelvic mass was an incidental 
finding with negative tumor markers. Although tumor es-
trogenic activity could be manifested as vaginal bleeding, 
in our study 5 patients presented with abdominal pain and 
others were asymptomatic. An ovarian mass and an elevated 
serum CA125 level generally suggest a malignant process 
in a postmenopausal woman. There are studies evaluat-
ing the predictive value of CA 125 level and malignancy, 
showing that tumor marker CA 125 alone is not suitable 
for distinguishing between benign and malignant adnexal 
mass [14]. Only 2 patients manifested elevated CA 125 level 
in blood and 1 of them ascites. Nine patients had RMI scores 
above 200 and were evaluated by an experienced sonog-
rapher. In 5 patients with positive RMI, frozen section was 
performed perioperatively; 4 patients were considered as 
benign according to the sonographer suggestion. About 1% 
of Brenner tumors are reported to be malignant in the lit-
erature [8, 15]. All Brenner tumors in our study were benign; 
therefore, we are unable to comment on the clinical status 
and further management of malignant Brenner tumors.
Transvaginal and transabdominal ultrasound performed 
by an experienced sonographer is a standard preoperative 
imaging method in our center for patients with adnexal 
masses. There are studies on rare ovarian tumors published 
which describe unique ultrasound features that may help 
to postulate a correct specific diagnosis before surgery. 
This is true in cases of struma ovarii (the “struma pearl”), 
granulosa cell tumors (“Swiss cheese appearance”), and 
Sertoli–Leydig cell tumors [16–18], but there are no unique 
features described in Brenner tumors so far. In Dierickx’s 
2012 report, experienced sonographers failed to describe 
unique ultrasound feature in 14 images of Brenner tumor 
and no other study has found specific characteristics either 
[11]. Many benign Brenner tumors manifest as entirely solid 
structure on ultrasound examination but some can appear 
as cystic with or without solid structures [7]. In our study, we 
described the sonographic features of 23 Brenner tumors 
of the ovary; seven tumors (30%) were cystic and 16 (70%) 
with complex appearance. Solid components were poorly 
vascularized on color Doppler. In the literature, calcifications 
have been reported of 50% of Brenner tumors on sonogra-
phy and 83% on CT [7]. Dierickx described calcifications on 
ultrasound scans in 13 (87%) of 15 benign Brenner tumors 
[11]. We reported 81% of Brenner tumors containing solid 
component revealed acoustic shadowing caused by vis-
ible calcifications. Therefore, we conclude that ultrasound 
signs of multiple calcifications could be a key feature for the 
diagnosis. Data on the laterality of Brenner tumor (whether 
right or left ovary) vary in the literature [3, 10, 19], but in 
our series, 82% of the Brenner tumors were detected in the 
left ovary. This is in concordance with the study published 
by Dierickx which reported unilateral lesions to be pre-
sent more common in the left ovary [4, 11]. In our series, 
4/23 (18%) Brenner tumors were bilateral. This is slightly 
above the range of 5–14% that is reported in the literature 
[10, 20]. There is an association of Brenner tumors with 
a second ovarian neoplasm noted and the rate of 30% is 
reported in the literature [8, 10, 15]. In our study, 26% of 
patients presented with an associated benign tumor: 2 were 
serous and 4 mucinous cystadenomas. Using subjective 
assessment, the sonographers correctly classified the ovar-
ian tumor as benign in 57% (13/23) of the tumors (in 1 tumor, 
the sonographer was uncertain) which represent real clini-
cal difficulties to differentiate benign Brenner tumor from 
Figure 6. Transvaginal ultrasound image of a solid benign Brenner 
tumor containing an anechoic cystic component described as 
malignant by sonographer
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ovarian malignancy. Preoperatively, ultrasound findings 
were discussed with the patients and each gave informed 
consent for a staging and radical debulking procedure in 
case of malignancy.
In our study, almost half (48%) of the patients underwent 
laparoscopy. There may be a general objection that the 
laparoscopic removal of a potentially malignant adnexal 
tumor increases the possibility of tumor spillage and port 
site metastasis development. Based on our experience, 
laparoscopic approach can be easily adopted not only for 
young, fertile-age patients but also for most patients — even 
postmenopausal — who require total hysterectomy with 
bilateral salpingo-oophorectomy for adnexal mass. In our 
series, the tumor was inserted safely into the endobag which 
enabled extraction from the abdomen without spilling po-
tentially malignant cells into the abdominal cavity. Con-
servative surgery is strongly advised for women with the 
potential and desire for fertility [9, 14]. 
We admit several limitations of our study. Firstly, this is 
a single institution retrospective study. The Brenner tumor is 
a rare tumor; therefore, it was necessary to collect cases over 
a long-time frame. Ultrasound data and examinations were 
retrieved by using several ultrasound devices. Although our 
series seems to be one of the largest, dealing with complex 
clinical, surgical data, ultrasound reports and descriptions; 
the number of cases (n = 23) remains small. Therefore, ul-
trasound features and characteristics of benign Brenner 
tumor may be biased. The strength of our study is based 
on a comprehensive unique database of clinical, surgical, 
and pathological data connected with highly experienced 
preoperative ultrasound performance. Our data demon-
strates real clinical difficulties arising from the ultrasound 
findings of such a strange adnexal mass. Due to the rareness 
of the Brenner tumor, more ultrasound and clinical data are 
needed, and our study may contribute to better insights 
into the proper and adequate management of this rare 
ovarian tumor.
CONCLUSIONS 
The variable sonographic picture of the ovarian Brenner 
tumor and its rare occurrence make ultrasound diagnosis 
very challenging. In the benign Brenner tumors, we failed to 
find one specific ultrasound feature that could easily charac-
terize this tumor. More probably, the complexity itself of the 
ultrasound picture, consisting of features such as calcifica-
tions with shadowing, poorly vascularized solid component, 
and a left-sided localization of the mass could be signs of 
a benign Brenner tumor and could help even an experienced 
sonographer in deciding whether the lesion is benign or 
malignant. In surgical management of the Brenner tumor, 
laparoscopy should be considered and preferred. We believe 
our study may contribute to the awareness of the Brenner 
tumor and thus minimize patients’ fear of an ovarian cancer 
diagnosis while also reducing the number of unnecessary 
laparotomies and extensive surgical procedures.
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